Talmajeong (Talniflumate)

Adult dose

Administer 370 mg of talniflumate orally 3 times daily. In severe cases, administer 740 mg per dose. Adjust the dose as appropriate according to age and symptoms.

This medication should be consulted with a doctor or pharmacist before use by individuals who regularly consume more than three glasses of alcohol daily, as it may cause gastrointestinal bleeding. This drug can increase the risk of cardiovascular disease, so patients with a history of heart disease or stroke, or those with risk factors, should exercise additional caution. Symptoms of cardiovascular issues should be carefully monitored by the doctor and the patient, and immediate action should be taken if symptoms arise. This medication carries a risk of serious gastrointestinal problems such as gastrointestinal bleeding, ulcers, and perforation. Special caution is needed for elderly patients or those with a history of gastrointestinal diseases; if gastrointestinal symptoms occur, immediate medical attention should be sought. Individuals with a history of peptic ulcers or allergies to this medication's components, as well as those with asthma or a history of aspirin allergies, should not use this medication. Moreover, it should not be administered to pregnant women, those who might become pregnant, nursing mothers, or patients with severe liver, kidney, or heart diseases. Patients with mild liver or kidney dysfunction, the elderly, and those taking diuretics should use this medication cautiously and have their condition frequently monitored. While taking this medication, adverse reactions such as nausea, vomiting, diarrhea, abdominal pain, skin rashes, dizziness may occur; if symptoms worsen, consultation with a doctor is advised. It is recommended not to take this medication in conjunction with other non-steroidal anti-inflammatory drugs, and since interactions may occur with certain medications, it's essential to inform the doctor of all medications currently being taken. In late pregnancy, it should not be used as it may affect the fetus; nursing mothers are advised to either stop breastfeeding or discontinue use of the medication. Children, especially those under 12 years old, should not be given this medication, and elderly patients should take the minimum effective dose with caution. This medication should be stored out of the reach of children and should not be transferred to another container.

• Gastrointestinal bleeding
• cardiovascular thrombotic reactions
• myocardial infarction
• stroke
• nausea
• vomiting
• photosensitivity
• asthma attacks
• systemic fatigue due to hypotension
• hypersensitivity shock

This medication should be stored in a tightly sealed container that prevents air and moisture from entering. This will help maintain the drug's efficacy for a longer period.

Appearance

Yellow round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle